To many, the Global Fund is known primarily as a source of funding—a place governments can turn to for an injection of cash for programs aimed at ending the scourges of AIDS, tuberculosis and malaria. And the Global Fund’s main use and focus of its innovative finance program has been on raising the funds needed to meet country demand for these otherwise unaffordable programs.
You are here
The Global Fund explores innovative finance instruments to help unlock financial flows from private and public sources
Pakistan’s funding request to the Global Fund prioritizes TB case notification and treating MDR-TB cases
Ukraine starts transition away from Global Fund support without a detailed transition plan, OIG says
TRP focuses on gaps in services for key populations in its review of Ethiopia's TB/HIV funding request to the Global Fund
When the Technical Review Panel (TRP) assessed Ethiopia’s TB/HIV funding request last Fall, it considered the request to be technically sound, but expressed concerns related to coverage of key populations.
Capacity issues and delays in implementation plague otherwise successful Global Fund grants to Zambia, OIG says
Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says
Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.
The Global Fund, the World Health Organization (WHO), the Stop TB Partnership and 13 countries with a high burden of TB have launched a program to find and treat an additional 1.5 million missing cases of TB by the end of 2019.
Working through the Global Fund Advocates Network (GFAN), tuberculosis (TB) advocates are looking to strategically advance efforts to combat the disease and take advantage of several key international meetings over the coming 15 months.
Two high-profile initiatives were launched late last year, each designed to shore up the response to the global tuberculosis epidemic.
The World Health Organization has issued new recommendations for the treatment of multi-drug-resistant TB, involving the use of a regimen that is shorter and cheaper compared to what is currently being used.